News & Events
Check out the latest in all things Cas-CLOVER and piggyBac with their implications, applications, and advantages in the real world.
Novel non-natural small molecules DM350-P and DM300 outperform natural cannabinoids, steroid and immune suppressant positive controls in a mouse Colitis ...
Lexington, KY and Bloomington, IN: A pioneering study, authored by scientists from Demeetra and Indiana University, has been selected for the ...
Meet our team for an introduction to our CRISPR alternative, Cas-CLOVER™. You can also catch us at our poster ...
Proud to Attend 23rd Annual PepTalk PepTalk provides a comprehensive program and innovative solutions in antibody development, biologics characterization, and ...
Proud to Attend the 31st Plant & Animal Genome Conference PAG31 is the premier and largest Ag genomics meeting in ...
Dublin, Ireland and Kentucky, USA, September 12: ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with ...
Demeetra & Hera At The 2023 Cultivated Meats Conference The Industrializing Cultivated Meats & Seafood Summit is your one-stop-shop for ...
Demeetra Was Proud to Present at BIO International 2023 Meet us at BIO International to discuss the latest in CRISPR ...
With more precision, high efficiency, flexible design, larger deletions & simpler screening, Cas-CLOVER surpasses Cas9 in a multitude of ...
Demeetra provides integrated genome engineering platforms, and products, backed by deep technical expertise.
Contact us to learn how our differentiated IP, flexible access models, and internal know-how can support adoption from discovery through bioprocessing and commercial use.